Igor Kruglyak Sr Advisor to the CEO at Avenga Igor is a 35+ year veteran executive of global key development and deployment projects. A dedicated technology solutions practice leader, he is an expert in managing on- and offshore value-based development, B2C, B2B and integration. Created with Sketch.
May 23, 2022 I Igor Kruglyak (Sr Advisor to the CEO at Avenga) How NLP maximizes the efficacy of clinical trials Article Pharma & Life Sciences AI Data & Analytics Discover the NLP social graph technique for better patient recruitment. Read more
Feb 07, 2022 I Igor Kruglyak (Sr Advisor to the CEO at Avenga) Pharma will innovate and prosper further: Top 10 pharmaceutical industry trends in 2022 Article Pharma & Life Sciences AI Technology Trends The Pharmaceutical Industry is facing a new realia and seeking for new ways to engage and enroll patients, use real-word-evidence, employ digital marketing, telehealth services and all possible innovative solutions. Read more
Feb 17, 2021 I Igor Kruglyak (Sr Advisor to the CEO at Avenga) Digital Transformation in the Pharmaceutical Industry From Drug Discovery to Pharmaceutical Manufacturing Article Pharma & Life Sciences AI Digital Transformation This article highlights how digital transformation of the life sciences industry accelerates drug discovery, streamlines clinical trials, eases up pharmaceutical manufacturing and improves drug safety. Read more
Dec 09, 2020 I Igor Kruglyak (Sr Advisor to the CEO at Avenga) 20 Examples of Wearables and IoT Disrupting Healthcare Article Pharma & Life Sciences AI Technology Trends IoT and wearables provide extra insights into particular symptoms and trends of a decease, enable more precise targeted treatments and allow for a better control by patients. Let’s have a look! Read more
Nov 29, 2020 I Igor Kruglyak (Sr Advisor to the CEO at Avenga) Natural Language Processing: Tasks and Application Areas Article All industries AI Data & Analytics While natural language processing is not independent enough to provide human-like experiences, the solutions that use NLP and ML techniques applied by humans, significantly improve business processes and decision-making. Read more
Nov 25, 2020 I Igor Kruglyak (Sr Advisor to the CEO at Avenga) With the Internet of Things, the Future of Healthcare is Already Here Article Pharma & Life Sciences Data & Analytics Technology Trends The impact of the Internet of Things in healthcare can address some critical issues that became apparent in 2020s, from process automation to logistics, to telemedicine, to clinical trial management. Explore more. Read more
Oct 22, 2020 I Igor Kruglyak (Sr Advisor to the CEO at Avenga) Virtual Clinical Trials Cut the Degree of Separation Between Patients and Investigators Article Pharma & Life Sciences Digital Transformation Although not new, virtual clinical trials have gone from being an interesting option to a pure necessity in 2020s. We explore key issues that virtual clinical trials are solving. Have a look. Read more
Sep 18, 2020 I Igor Kruglyak (Sr Advisor to the CEO at Avenga) Virtual Clinical Trials: The Pain of Change – Can Technology Heal the Pain? Article Pharma & Life Sciences Digital Transformation Together with our special guest, Chuck Piccirillo, we discussed the technology potential for virtual clinical trials, and also the mechanisms to facilitate participation in clinical trials. Have a closer look. Read more
Sep 17, 2020 I Igor Kruglyak (Sr Advisor to the CEO at Avenga) Overview of Digital Solutions for Drug Commercialization Article Pharma & Life Sciences Data & Analytics Digital Transformation Digital technology helps pharma and life sciences to drive the commercial potential for the newly developed drugs and transform them into that benefit not only the researchers and sponsors, but also all of humankind. Read more
Jul 21, 2020 I Igor Kruglyak (Sr Advisor to the CEO at Avenga) Essentially, Data Is Good. It’s the Use Cases That Can Be Problematic Article Pharma & Life Sciences Data & Analytics Data as a property and data ownership were the topic we addressed during our webinar on Reframing Data and Privacy: The new ethics, optics and relationships. Our special guest, Michael DePalma shars a number of points. Read more
